کالا آزار (Urdu Wikipedia)

Analysis of information sources in references of the Wikipedia article "کالا آزار" in Urdu language version.

refsWebsite
Global rank Urdu rank
4th place
26th place
2nd place
11th place
195th place
223rd place
1st place
1st place
1,053rd place
466th place

collinsdictionary.com

doi.org

  • MP Barrett؛ Croft, SL (2012)۔ "Management of trypanosomiasis and leishmaniasis."۔ British medical bulletin۔ ج 104: 175–96۔ DOI:10.1093/bmb/lds031۔ PMC:3530408۔ PMID:23137768
  • S Sundar؛ Chakravarty, J (جنوری 2013)۔ "Leishmaniasis: an update of current pharmacotherapy."۔ Expert opinion on pharmacotherapy۔ ج 14 شمارہ 1: 53–63۔ DOI:10.1517/14656566.2013.755515۔ PMID:23256501
  • TP Dorlo؛ Balasegaram, M؛ Beijnen, JH؛ de Vries, PJ (نومبر 2012)۔ "Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis."۔ The Journal of antimicrobial chemotherapy۔ ج 67 شمارہ 11: 2576–97۔ DOI:10.1093/jac/dks275۔ PMID:22833634
  • P Minodier؛ Parola, P (مئی 2007)۔ "Cutaneous leishmaniasis treatment."۔ Travel medicine and infectious disease۔ ج 5 شمارہ 3: 150–8۔ DOI:10.1016/j.tmaid.2006.09.004۔ PMID:17448941
  • R Lozano (15 دسمبر 2012)۔ "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010."۔ Lancet۔ ج 380 شمارہ 9859: 2095–128۔ DOI:10.1016/S0140-6736(12)61728-0۔ PMID:23245604
  • SA Ejazi؛ Ali, N (جنوری 2013)۔ "Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects."۔ Expert review of anti-infective therapy۔ ج 11 شمارہ 1: 79–98۔ DOI:10.1586/eri.12.148۔ PMID:23428104

nih.gov

pubmed.ncbi.nlm.nih.gov

  • MP Barrett؛ Croft, SL (2012)۔ "Management of trypanosomiasis and leishmaniasis."۔ British medical bulletin۔ ج 104: 175–96۔ DOI:10.1093/bmb/lds031۔ PMC:3530408۔ PMID:23137768
  • S Sundar؛ Chakravarty, J (جنوری 2013)۔ "Leishmaniasis: an update of current pharmacotherapy."۔ Expert opinion on pharmacotherapy۔ ج 14 شمارہ 1: 53–63۔ DOI:10.1517/14656566.2013.755515۔ PMID:23256501
  • TP Dorlo؛ Balasegaram, M؛ Beijnen, JH؛ de Vries, PJ (نومبر 2012)۔ "Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis."۔ The Journal of antimicrobial chemotherapy۔ ج 67 شمارہ 11: 2576–97۔ DOI:10.1093/jac/dks275۔ PMID:22833634
  • P Minodier؛ Parola, P (مئی 2007)۔ "Cutaneous leishmaniasis treatment."۔ Travel medicine and infectious disease۔ ج 5 شمارہ 3: 150–8۔ DOI:10.1016/j.tmaid.2006.09.004۔ PMID:17448941
  • R Lozano (15 دسمبر 2012)۔ "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010."۔ Lancet۔ ج 380 شمارہ 9859: 2095–128۔ DOI:10.1016/S0140-6736(12)61728-0۔ PMID:23245604
  • SA Ejazi؛ Ali, N (جنوری 2013)۔ "Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects."۔ Expert review of anti-infective therapy۔ ج 11 شمارہ 1: 79–98۔ DOI:10.1586/eri.12.148۔ PMID:23428104

ncbi.nlm.nih.gov

web.archive.org

  • "Leishmaniasis Fact sheet N°375"۔ World Health Organization۔ جنوری 2014۔ 2019-01-07 کو اصل سے آرکائیو کیا گیا۔ اخذ شدہ بتاریخ 2014-02-17
  • "Leishmaniasis Magnitude of the problem"۔ World Health Organization۔ 2019-01-07 کو اصل سے آرکائیو کیا گیا۔ اخذ شدہ بتاریخ 2014-02-17

who.int

  • "Leishmaniasis Fact sheet N°375"۔ World Health Organization۔ جنوری 2014۔ 2019-01-07 کو اصل سے آرکائیو کیا گیا۔ اخذ شدہ بتاریخ 2014-02-17
  • "Leishmaniasis Magnitude of the problem"۔ World Health Organization۔ 2019-01-07 کو اصل سے آرکائیو کیا گیا۔ اخذ شدہ بتاریخ 2014-02-17